Fresenius Medical Care Expands Serbian Production of Bloodlines
Stock Chart for Fresenius Medical Care AG & Co KGaA (FME)
Fresenius Medical Care AG, the world’s biggest provider of kidney dialysis, said it has expanded production of bloodlines by a third at its Serbian plant.
The addition will increase output to 12 million sets a year at the factory in Vrsac, northeastern Serbia, the company said in an e-mailed statement. The plant also produces concentrates for dialysis kits.
Fresenius, which operates five dialysis clinics in Serbia, plans to add a second factory in Vrsac in 2014 to double production of bloodlines to 24 million units, the company said.
To contact the reporter on this story: Misha Savic in Belgrade at firstname.lastname@example.org
To contact the editor responsible for this story: James M. Gomez at email@example.com
Bloomberg reserves the right to edit or remove comments but is under no obligation to do so, or to explain individual moderation decisions.